首页> Blood advances> Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.

Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.

导出 LinkOut

翻译打印收藏纠错

第一作者： Armin,Ghobadi

第一单位： Division of Oncology, Washington University School of Medicine, St Louis, MO.

作者： Armin,Ghobadi ^[1] ; Jack H,Landmann ^[1] ; Alun,Carter ^[1] ; Matthew L,Cooper ^[1] ; Mehmet Emrah,Selli ^[1] ; Jufang,Chang ^[1] ; Matthew,Baker ^[2] ; Christopher A,Miller ^[1] ; Francesca,Ferraro ^[1] ; David Y,Chen ^[1] ; Amanda M,Smith ^[1] ; Taylor A,LaValle ^[1] ; Eric J,Duncavage ^[1] ; Justin,Chou ^[3] ; Victor,Tam ^[3] ; Joseph M,Benoun ^[3] ; Jenny,Nater ^[3] ; Nathalie,Scholler ^[3] ; Francesca,Milletti ^[3] ; Remus,Vezan ^[3] ; Adrian,Bot ^[3] ; John M,Rossi ^[3] ; Nathan,Singh ^[1]

作者单位： Division of Oncology, Washington University School of Medicine, St Louis, MO. ^[1] The University of Texas Health Science Center at Houston, Houston, TX.;Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX. ^[2] Kite, a Gilead Company, Santa Monica, CA. ^[3]

医学主题词抗原, CD19(Antigens, CD19);免疫疗法(Immunotherapy);基因组学(Genomics)

DOI 10.1182/bloodadvances.2022007705

PMID 35858291

发布时间 2023-07-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood advances

2022年6卷20期

5634-5640页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Blood advances

2022年6卷20期

5634-5640页

检索历史清除

Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

检索历史清除